002864 盘龙药业
已收盘 10-30 15:00:00
资讯
新帖
简况
股市必读:盘龙药业三季报 - 第三季度单季净利润同比下降52.25%
证券之星 · 10-30 07:49
股市必读:盘龙药业三季报 - 第三季度单季净利润同比下降52.25%
盘龙药业(002864)9月30日股东户数2.27万户,较上期增加17.73%
证券之星 · 10-29 19:08
盘龙药业(002864)9月30日股东户数2.27万户,较上期增加17.73%
图解盘龙药业三季报:第三季度单季净利润同比下降52.25%
证券之星 · 10-29 03:09
图解盘龙药业三季报:第三季度单季净利润同比下降52.25%
盘龙药业(002864)披露首次回购公司股份公告,10月21日股价上涨0.94%
证券之星 · 10-21
盘龙药业(002864)披露首次回购公司股份公告,10月21日股价上涨0.94%
补税潮持续:盘龙药业缴清1670万元税费,同步完成235万元首次股份回购
深圳商报·读创 · 10-21
补税潮持续:盘龙药业缴清1670万元税费,同步完成235万元首次股份回购
盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会在京顺利举行!
中金财经 · 10-14
盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会在京顺利举行!
股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》
证券之星 · 10-09
股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》
股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》
证券之星 · 10-08
股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》
股市必读:盘龙药业新发布《第五届董事会第十次会议决议公告》
证券之星 · 09-23
股市必读:盘龙药业新发布《第五届董事会第十次会议决议公告》
盘龙药业(002864)披露调整2026年股票期权激励计划行权价格及数量公告,9月22日股价下跌0.33%
证券之星 · 09-22
盘龙药业(002864)披露调整2026年股票期权激励计划行权价格及数量公告,9月22日股价下跌0.33%
盘龙药业(002864)披露完成工商变更登记并换发营业执照公告,9月11日股价下跌2.61%
证券之星 · 09-11
盘龙药业(002864)披露完成工商变更登记并换发营业执照公告,9月11日股价下跌2.61%
股市必读:盘龙药业新发布《关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告》
证券之星 · 09-03
股市必读:盘龙药业新发布《关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告》
股市必读:盘龙药业新发布《关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告》
证券之星 · 09-02
股市必读:盘龙药业新发布《关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告》
盘龙药业(002864)披露回购公司股份进展情况公告,9月1日股价上涨2.84%
证券之星 · 09-01
盘龙药业(002864)披露回购公司股份进展情况公告,9月1日股价上涨2.84%
盘龙药业(002864)2026年中报简析:净利润同比下降29.53%
证券之星 · 08-29
盘龙药业(002864)2026年中报简析:净利润同比下降29.53%
盘龙药业中报:现金流激增夯实经营底盘,核心单品市场份额提升,中期分红叠加回购彰显发展信心
证券之星 · 08-28
盘龙药业中报:现金流激增夯实经营底盘,核心单品市场份额提升,中期分红叠加回购彰显发展信心
盘龙药业:业务结构升级落地显效,双资质加持打开新增长空间
中金财经 · 08-28
盘龙药业:业务结构升级落地显效,双资质加持打开新增长空间
股市必读:盘龙药业新发布《关于2026年半年度利润分配方案的公告》
证券之星 · 08-28
股市必读:盘龙药业新发布《关于2026年半年度利润分配方案的公告》
图解盘龙药业中报:第二季度单季净利润同比下降28.63%
证券之星 · 08-28
图解盘龙药业中报:第二季度单季净利润同比下降28.63%
股市必读:盘龙药业(002864)8月4日董秘有最新回复
证券之星 · 08-05
股市必读:盘龙药业(002864)8月4日董秘有最新回复
加载更多
公司概况
公司名称:
陕西盘龙药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2017-11-16
主营业务:
陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售。公司的主要产品是盘龙七片、盘龙七药酒、金茵利胆胶囊、克比热提片、复方醋酸棉酚片、醋酸棉酚原料药、骨胶归珍片、盘龙七贴。截至本报告期末,公司荣获“国家级绿色工厂”及第七届“全国文明单位”,成功取得中国合格评定国家认可委员会(CNAS)实验室认可证书;2026年上半年新增获评“国家知识产权强国建设示范创建对象”“省级高技能人才培训基地”,入选“全国‘双化协同’典型案例”等多项荣誉资质。
发行价格:
10.03
{"stockData":{"symbol":"002864","market":"SZ","secType":"STK","nameCN":"盘龙药业","latestPrice":19.41,"timestamp":1793343825000,"preClose":19.5,"halted":0,"volume":1669019,"delay":0,"changeRate":-0.0046,"floatShares":98596700,"shares":137000000,"eps":0.461,"marketStatus":"已收盘","change":-0.09,"latestTime":"10-30 15:00:00","open":19.5,"high":19.99,"low":19.21,"amount":32841700,"amplitude":0.04,"askPrice":19.42,"askSize":167,"bidPrice":19.41,"bidSize":198,"shortable":0,"etf":0,"ttmEps":0.461,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":19.5,"symbolType":"stock","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":21.45,"lowLimit":17.55,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":136700928,"isCdr":false,"pbRate":1.56,"roa":"--","peRate":42.104121,"roe":"3.31%","epsLYR":0.92,"committee":0.331092,"marketValue":2653000000,"turnoverRate":0.0169,"status":1,"floatMarketCap":1914000000},"requestUrl":"/m/hq/s/002864/","defaultTab":"news","newsList":[{"id":"2679976253","title":"股市必读:盘龙药业三季报 - 第三季度单季净利润同比下降52.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679976253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679976253?lang=zh_cn&edition=full","pubTime":"2026-10-30 07:49","pubTimestamp":1793317773,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年前三季度归母净利润5654.45万元,同比下降37.04%;第三季度单季归母净利润1416.84万元,同比下降52.25%。公司公告汇总关于2026年前三季度利润分配方案的公告陕西盘龙药业集团股份有限公司于2026年10月27日召开第五届董事会第十一次会议,审议通过2026年前三季度利润分配方案。本次利润分配金额占当期归属于上市公司股东净利润的12.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000014216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679140393","title":"盘龙药业(002864)9月30日股东户数2.27万户,较上期增加17.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679140393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679140393?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:08","pubTimestamp":1793272129,"startTime":"0","endTime":"0","summary":"证券之星消息,近日盘龙药业披露,截至2026年9月30日公司股东户数为2.27万户,较6月30日增加3420.0户,增幅为17.73%。在中药行业个股中,盘龙药业股东户数低于行业平均水平,截至9月30日,中药行业平均股东户数为5.34万户。从股价来看,2026年6月30日至2026年9月30日,盘龙药业区间涨幅为7.54%,在此期间股东户数增加3420.0户,增幅为17.73%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900045966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679376415","title":"图解盘龙药业三季报:第三季度单季净利润同比下降52.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679376415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679376415?lang=zh_cn&edition=full","pubTime":"2026-10-29 03:09","pubTimestamp":1793214566,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业2026年三季报显示,前三季度公司主营收入6.18亿元,同比下降26.56%;归母净利润5654.45万元,同比下降37.04%;扣非净利润5111.45万元,同比下降38.02%;其中2026年第三季度,公司单季度主营收入1.95亿元,同比下降26.94%;单季度归母净利润1416.84万元,同比下降52.25%;单季度扣非净利润1262.63万元,同比下降57.36%;负债率25.2%,投资收益-17.49万元,财务费用-826.5万元,毛利率57.69%。财报数据概要请见下图:本文数据来源于盘龙药业2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677331608","title":"盘龙药业(002864)披露首次回购公司股份公告,10月21日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677331608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677331608?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:50","pubTimestamp":1792594226,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘,盘龙药业报收于20.34元,较前一交易日上涨0.94%,最新总市值为27.8亿元。该股当日开盘20.26元,最高20.51元,最低20.23元,成交额达2529.7万元,换手率为1.26%。近日,盘龙药业披露《关于首次回购公司股份的公告》。本次回购符合相关法规及公司既定回购方案。公司已于2026年8月26日审议通过回购股份方案,拟使用自有资金1,000万元至2,000万元回购股份,用于员工持股计划或股权激励,回购价格上限调整为35.82元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677676975","title":"补税潮持续:盘龙药业缴清1670万元税费,同步完成235万元首次股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2677676975","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677676975?lang=zh_cn&edition=full","pubTime":"2026-10-21 19:40","pubTimestamp":1792582804,"startTime":"0","endTime":"0","summary":"10月21日晚间,盘龙药业(002864)发布税务事项公告,公司及其控股子公司本年度自查补缴税款金额累计达到1415万元,滞纳金为255万元,合计补缴税款及滞纳金为1670万元,占公司最近一个会计年度经审计净利润的17.34%。截至公告披露日,上述税款及滞纳金已全部缴纳完毕,且本次补缴事项不涉及行政处罚。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610213902820059.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610213902820059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675399655","title":"盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会在京顺利举行!","url":"https://stock-news.laohu8.com/highlight/detail?id=2675399655","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675399655?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:10","pubTimestamp":1791940201,"startTime":"0","endTime":"0","summary":"10月13日,盘龙药业“盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会”于北京经济技术开发区(亦庄)举行。随着北京盘龙健康智创中心正式启新,盘龙药业“西安+北京”双总部格局浮出水面,运行多年的“一体两翼三纵深”战略也由此打开全新维度。本次北京盘龙健康智创中心的设立,正是“一体两翼三纵深”战略在研发纵深、营销纵深两大板块的关键落子。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/14/20261014982848.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/14/20261014982848.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20261014/32395999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IBBQ","002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674500777","title":"股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674500777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674500777?lang=zh_cn&edition=full","pubTime":"2026-10-09 04:00","pubTimestamp":1791489639,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年9月30日,盘龙药业累计回购股份0股,支付金额0元,回购尚未启动。公司公告汇总关于回购公司股份进展情况的公告陕西盘龙药业集团股份有限公司于2026年8月26日召开董事会,审议通过以集中竞价交易方式回购公司股份的方案,拟用于员工持股计划或股权激励,回购资金总额不低于1,000万元且不超过2,000万元,实施期限为12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900003130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673010946","title":"股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673010946","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673010946?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:58","pubTimestamp":1791403089,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘,盘龙药业报收于21.05元,上涨0.72%,换手率1.35%,成交量1.34万手,成交额2814.67万元。当日关注点交易信息汇总:9月30日主力资金净流入16.88万元,游资资金净流入91.15万元,散户资金净流出108.03万元。公司公告汇总:截至2026年9月30日,盘龙药业累计回购股份0股,支付金额0元,回购尚未启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669629121","title":"股市必读:盘龙药业新发布《第五届董事会第十次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669629121","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669629121?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:30","pubTimestamp":1790101834,"startTime":"0","endTime":"0","summary":"关于调整公司2026年股票期权激励计划期权行权价格及数量的公告盘龙药业于2026年9月21日召开第五届董事会第十次会议,审议通过《关于调整公司2026年股票期权激励计划期权行权价格及数量的议案》;调整依据为2025年年度权益分派及2026年半年度权益分派,调整后股票期权数量为485,550份,行权价格为23.64元/份;本次调整无需提交股东会审议,不会对公司财务状况和经营成果产生重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148773","title":"盘龙药业(002864)披露调整2026年股票期权激励计划行权价格及数量公告,9月22日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148773","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669148773?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:46","pubTimestamp":1790070389,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘,盘龙药业报收于21.36元,较前一交易日下跌0.33%,最新总市值为29.2亿元。该股当日开盘21.29元,最高21.58元,最低21.13元,成交额达4155.99万元,换手率为1.98%。陕西盘龙药业集团股份有限公司于2026年9月21日召开第五届董事会第十次会议,审议通过了《关于调整公司2026年股票期权激励计划期权行权价格及数量的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200031320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666578977","title":"盘龙药业(002864)披露完成工商变更登记并换发营业执照公告,9月11日股价下跌2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666578977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666578977?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:35","pubTimestamp":1789137317,"startTime":"0","endTime":"0","summary":"近日,陕西盘龙药业集团股份有限公司披露《关于公司完成工商变更登记并换发营业执照的公告》。公告显示,公司因实施2025年度利润分配及资本公积金转增股本,以及回购注销2022年限制性股票,导致总股本和注册资本发生变化。变更后公司注册资本由10,628.096万元增至13,670.0928万元,总股本为136,700,928股。相关工商变更手续已办理完毕,并取得陕西省市场监督管理局颁发的新营业执照。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664846310","title":"股市必读:盘龙药业新发布《关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664846310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664846310?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:50","pubTimestamp":1788375023,"startTime":"0","endTime":"0","summary":"公司公告汇总:披露回购决议前一交易日前十大股东及前十大无限售条件股东持股情况,谢晓林合计持股48,346,912股,其中无限售条件股份12,086,728股。公司公告汇总关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告陕西盘龙药业集团股份有限公司于2026年8月26日召开第五届董事会第九次会议,审议通过《关于以集中竞价交易方式回购公司股份方案的议案》。截至2026年8月31日,公司尚未实施回购,累计回购股份数量为0股,支付金额为0元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664865451","title":"股市必读:盘龙药业新发布《关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664865451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664865451?lang=zh_cn&edition=full","pubTime":"2026-09-02 02:44","pubTimestamp":1788288253,"startTime":"0","endTime":"0","summary":"公司公告汇总关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告陕西盘龙药业集团股份有限公司于2026年8月26日召开第五届董事会第九次会议,审议通过《关于以集中竞价交易方式回购公司股份方案的议案》。截至2026年8月27日,前十大股东中谢晓林持股48,346,912股,占总股本35.37%;前十大无限售条件股东中谢晓林持股12,086,728股,占无限售条件股份总数12.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200002538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485703","title":"盘龙药业(002864)披露回购公司股份进展情况公告,9月1日股价上涨2.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664485703?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:58","pubTimestamp":1788274690,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,盘龙药业报收于22.45元,较前一交易日上涨2.84%,最新总市值为30.69亿元。近日,盘龙药业发布《关于回购公司股份进展情况的公告》。公告显示,公司于2026年8月26日召开第五届董事会第九次会议,审议通过以集中竞价交易方式回购公司股份的方案,拟用于员工持股计划或股权激励。回购期限为董事会审议通过之日起12个月内。截至2026年8月31日,公司尚未实施回购,累计回购股份数量为0股,支付金额为0元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663161150","title":"盘龙药业(002864)2026年中报简析:净利润同比下降29.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663161150","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663161150?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:29","pubTimestamp":1787956185,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期盘龙药业发布2026年中报。根据财报显示,盘龙药业净利润同比下降29.53%。截至本报告期末,公司营业总收入4.23亿元,同比下降26.38%,归母净利润4237.61万元,同比下降29.53%。按单季度数据看,第二季度营业总收入2.0亿元,同比下降38.22%,第二季度归母净利润2061.52万元,同比下降28.63%。去年的净利率为8.42%,算上全部成本后,公司产品或服务的附加值一般。本文数据来源于盘龙药业2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900011442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662054556","title":"盘龙药业中报:现金流激增夯实经营底盘,核心单品市场份额提升,中期分红叠加回购彰显发展信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2662054556","media":"证券之星","labels":["dataReport","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662054556?lang=zh_cn&edition=full","pubTime":"2026-08-28 14:47","pubTimestamp":1787899677,"startTime":"0","endTime":"0","summary":"基于充沛的现金流与良好的财务状况,盘龙药业同步推出中期分红与股份回购双重举措,充分彰显管理层对公司长期价值的信心。截至目前,盘龙药业产品已覆盖5600余家等级医疗机构;同步深耕第二、第三终端,精准渗透33000余家零售药房及23000余家基层医疗单元,形成医疗与零售双轮驱动的立体格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026082800030469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864","159399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036037","title":"盘龙药业:业务结构升级落地显效,双资质加持打开新增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036037","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662036037?lang=zh_cn&edition=full","pubTime":"2026-08-28 09:30","pubTimestamp":1787880602,"startTime":"0","endTime":"0","summary":"2026年上半年,盘龙药业保持稳健经营态势,资产规模稳步提升,资产结构持续优化。在内部管控方面,盘龙药业持续提升资金使用效率,严控非必要开支,实现了降本增效的经营目标,上半年销售费用同比下降19.59%。截至半年报披露日,盘龙药业核心产品盘龙七片成功新增纳入国家基本药物目录,形成“医保甲类+基药”双重资质壁垒,进一步夯实细分领域竞争优势。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/28/20260828353646.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/28/20260828353646.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260828/32351157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033655","title":"股市必读:盘龙药业新发布《关于2026年半年度利润分配方案的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033655","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662033655?lang=zh_cn&edition=full","pubTime":"2026-08-28 04:32","pubTimestamp":1787862734,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘,盘龙药业报收于22.77元,上涨0.84%,换手率2.92%,成交量2.88万手,成交额6540.25万元。公司公告汇总:截至2026年期末,非经营性资金往来余额合计18,573.89万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662809340","title":"图解盘龙药业中报:第二季度单季净利润同比下降28.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662809340","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662809340?lang=zh_cn&edition=full","pubTime":"2026-08-28 03:28","pubTimestamp":1787858921,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业2026年中报显示,上半年度公司主营收入4.23亿元,同比下降26.38%;归母净利润4237.61万元,同比下降29.53%;扣非净利润3848.82万元,同比下降27.18%;其中2026年第二季度,公司单季度主营收入2.0亿元,同比下降38.22%;单季度归母净利润2061.52万元,同比下降28.63%;单季度扣非净利润1847.4万元,同比下降23.36%;负债率25.97%,投资收益-11.02万元,财务费用-185.95万元,毛利率57.72%。财报数据概要请见下图:本文数据来源于盘龙药业2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800006797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657565000","title":"股市必读:盘龙药业(002864)8月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657565000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657565000?lang=zh_cn&edition=full","pubTime":"2026-08-05 03:23","pubTimestamp":1785871429,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘,盘龙药业报收于21.24元,上涨1.68%,换手率2.74%,成交量2.7万手,成交额5725.24万元。董秘最新回复投资者: 尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年7月31日A股股东人数是多少?根据信息披露相关规定,公司将在定期报告中披露期末股东户数。相关定期数据请留意后续半年报公告,感谢您的理解与支持。当日关注点交易信息汇总:8月4日主力资金净流出12.51万元,占总成交额0.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500003878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793380079649,"stockEarnings":[{"period":"1week","weight":-0.0485},{"period":"1month","weight":-0.0779},{"period":"3month","weight":-0.0573},{"period":"6month","weight":-0.154},{"period":"1year","weight":-0.1421},{"period":"ytd","weight":-0.1705}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"陕西盘龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22714人(较上一季度增加17.73%)","perCapita":"4340股","listingDate":"2017-11-16","address":"陕西省商洛市柞水县盘龙生态产业园","registeredCapital":"13670万元","survey":" 陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售。公司的主要产品是盘龙七片、盘龙七药酒、金茵利胆胶囊、克比热提片、复方醋酸棉酚片、醋酸棉酚原料药、骨胶归珍片、盘龙七贴。截至本报告期末,公司荣获“国家级绿色工厂”及第七届“全国文明单位”,成功取得中国合格评定国家认可委员会(CNAS)实验室认可证书;2026年上半年新增获评“国家知识产权强国建设示范创建对象”“省级高技能人才培训基地”,入选“全国‘双化协同’典型案例”等多项荣誉资质。","listedPrice":10.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盘龙药业,002864,盘龙药业股票,盘龙药业股票老虎,盘龙药业股票老虎国际,盘龙药业行情,盘龙药业股票行情,盘龙药业股价,盘龙药业股市,盘龙药业股票价格,盘龙药业股票交易,盘龙药业股票购买,盘龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}